ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, and the Inte...

CRF Health, the leading global provider of patient-centred eSource technology and service solutions for the life sciences industry, today announced that its TrialMax ...

New clinical trials of monoclonal antibodies (mAb), have grown 115% globally over the ten year period 2007–2016 according to GlobalData, a leading data and analytics ...

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has reached a significant milestone in its nearly...

CPhI Worldwide, organised by UBM, announces the winners of the prestigious 2017 CPhI Pharma Awards during a live gala dinner at the Intercontinental Hotel in Frankfur...

Biogen will continue to lead the ongoing Phase 3 development of aducanumab and will remain solely responsible for all development costs for aducanumab until April 201...

The new-drug pipeline is bursting with innovative treatments in clinical trials while the industry is growing by leaps and bounds. Many biotech stocks are catching th...

Global Blood Therapeutics (GBT) has decided to terminate the GBT440 program for the treatment of idiopathic pulmonary fibrosis (IPF). The company has taken the decisi...

Switzerland-based oncology drug discovery and development company ADC Therapeutics (ADCT) has closed $200m private financing to fund registrational trials of its two ...